Nearly one million tablets of the Favipiravir antiviral drug are being consumed per day by COVID-19 patients in Thailand, according to the Public Health Ministry, as new records of infections…
Read More
Nearly one million tablets of the Favipiravir antiviral drug are being consumed per day by COVID-19 patients in Thailand, according to the Public Health Ministry, as new records of infections…
Read More
The new syrup form of Favipiravir antiviral COVID-19 medication, developed by Chulabhorn Royal Academy (CRA), Chulalongkorn University’s Faculty of Pharmaceutical Sciences and Thai research organization Medica Innova, will be available…
Read More
A patent application for Japanese-made anti-viral drug Favipiravir has been rejected by Thailand’s Intellectual Property Department over its manufacturing quality. The department’s director-general, Mr. Vuttikrai Leewiraphan, said yesterday (Wednesday) that…
Read More
Thailand will have procured up to 61 million doses of COVID-19 vaccines by the end of this year, which should be sufficient to cope with the pandemic, said Prime Minister…
Read More
Although most COVID-19 patients in Thailand will not be treated with Favipiravir since their symptoms are too mild, the country is still using more than 20,000 pills of this antiviral…
Read More
Thailand’s Government Pharmaceutical Organization (GPO) has recently entered into contract negotiations to procure one million tablets of Favipiravir, and anti-viral drug used in the treatment of COVID-19 patients, and is…
Read More
Thailand is expected to be able to produce the anti-viral drug, Favipiravir, early next year, Mrs. Nanthakarn Suwanpidokkul, a special specialist attached to the Government Pharmaceutical Organization (GPO), said today….
Read MorePage 1 of 1